reference/31005068

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31005068

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	293
issn	1573-7217 0167-6806
issueIdentifier	2
pageRange	281-293
publicationName	Breast Cancer Research and Treatment
startingPage	281
bibliographicCitation	McNamara KM, Yoda T, Nurani AM, Shibahara Y, Miki Y, Wang L, Nakamura Y, Suzuki K, Yang Y, Abe E, Hirakawa H, Suzuki T, Nemoto N, Miyashita M, Tamaki K, Ishida T, Brown KA, Ohuchi N, Sasano H. Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes. Breast Cancer Research and Treatment. 2014 Apr 09;145(2):281–93. doi: 10.1007/s10549-014-2942-6.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e322ccedf8270f20195fa068fca16236 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a3fa3472e998b5fa1b0b1886b7791e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af02cbf07535cece99e251b3c1bb586b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6404ff252d1b2ca25628b63e02c1f5f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1bc07192513c0190361ed5b4a6a8417 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b0e651a197095f51c9e157c19a4fa6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bcc94cbdd2cf74f6aaf2b7ea3ca9f12 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e16c59d6d6ea3e621e7cf7febb11b36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e975e4233386d1ee28e9c6e96d8e3ef2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8da0109da7e9ae83b8ecfe4ddf987643 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd4d523c744ad3d2ac291a9864cae2f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd19a934381c6e76a87f5aa07c0ba44f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ec9238661d2dfb4181ac5b65f8a9171 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef63e8fe378c0e032633b59c088f4525 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aca30a4d11491b0b61467983dd3fef5e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_304998bae4587d8977abc8d5b57b8c72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f501c215730a3d1c9420bf9acfcd86f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8446748060bb2481a2ad307dc2121f9
date	2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s10549-014-2942-6 https://pubmed.ncbi.nlm.nih.gov/24715382
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1254 https://portal.issn.org/resource/ISSN/0167-6806 https://portal.issn.org/resource/ISSN/1573-7217
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
discusses	http://id.nlm.nih.gov/mesh/M0494547 http://id.nlm.nih.gov/mesh/M0366130 http://id.nlm.nih.gov/mesh/M0010781 http://id.nlm.nih.gov/mesh/M0468194 http://id.nlm.nih.gov/mesh/M0018556 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M000626540 http://id.nlm.nih.gov/mesh/M0023219 http://id.nlm.nih.gov/mesh/M0072874 http://id.nlm.nih.gov/mesh/M0001106 http://id.nlm.nih.gov/mesh/M0020414 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0494509
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10184 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68245 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7164 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID367

Total number of triples: 62.